SCHEMBL9932470

SCHEMBL9932470

CC(=O)Oc1cc2c(c3cc(F)cc(F)c13)-c1ccccc1C2(C)C

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 3/20 0.33
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
HTT P42858 3/20 0.33
CYP4F2 P78329 1/20 0.33
CYP4A11 Q02928 1/20 0.33
BACE1 P56817 1/20 0.32
LMNA P02545 3/20 0.31
ALDH1A1 P00352 3/20 0.31
TSHR P16473 2/20 0.31
USP2 O75604 2/20 0.31
MAPT P10636 2/20 0.31
RECQL P46063 1/20 0.31
KDM4E B2RXH2 3/20 0.31
HSD17B10 Q99714 2/20 0.31
CYP1A2 P05177 1/20 0.31
CYP2C9 P11712 1/20 0.31
SLC22A6 Q4U2R8 1/20 0.31
HPGD P15428 2/20 0.31
ESR1 P03372 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1814483 0.80 HTT (0.48) MEN1KMT2AHTTBACE1LMNA
SCHEMBL16704916 0.80 MEN1 (0.30) MEN1KMT2AHTTLMNAALDH1A1
SCHEMBL9932870 0.79 PDK2 (0.35) PGRMEN1KMT2AKDM4EESR1
SCHEMBL9934689 0.74 ABCB11 (0.41) PGRMEN1KMT2AHTTLMNA
SCHEMBL9932915 0.74 BACE1 (0.42) PGRMEN1KMT2AHTTBACE1
SCHEMBL9931978 0.74 BACE1 (0.42) PGRMEN1KMT2AHTTBACE1
SCHEMBL1814669 0.68 HTT (0.43) KMT2AHTTBACE1LMNAALDH1A1
SCHEMBL16713272 0.67 KDM4E (0.35) HTTLMNAMAPTKDM4EHSD17B10
SCHEMBL9940214 0.66 MAOA (0.31)
SCHEMBL9933463 0.65 PDK2 (0.34) MEN1KMT2AALDH1A1USP2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9073838-B2 Method of making indeno-fused naphthol materials TRANSITIONS OPTICAL, INC. (US) 2015-07-07 US disclosed
US-20140364618-A1 Method of Making Indeno-Fused Naphthol Materials TRANSITIONS OPTICALS, INC. (US) 2014-12-11 US disclosed
US-8765978-B2 Method of making indeno-fused naphthol materials TRANSITIONS OPTICAL, INC. (US) 2014-07-01 US disclosed
WO-2012082837-A1 METHOD OF MAKING INDENO-FUSED NAPHTHOL MATERIALS TRANSITIONS OPTICAL, INC. (US) 2012-06-21 WO disclosed
US-20120157696-A1 METHOD OF MAKING INDENO-FUSED NAPHTHOL MATERIALS TRANSITIONS OPTICAL, INC. (US) 2012-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140364618-A1 Method of Making Indeno-Fused Naphthol Materials IDH3A, NQO1, IDH3B PGR 128/4885MEN1 595/4885KMT2A 1373/4885
US-20120157696-A1 METHOD OF MAKING INDENO-FUSED NAPHTHOL MATERIALS NQO1, IDH3A, IDH2 PGR 263/4885MEN1 903/4885KMT2A 1788/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.